Science

BioNTech shifts focus from COVID-19 vaccines to mRNA-based cancer therapies, aiming for market entry by 2026. Earnings per share fell to €1.08, surpassing expectations of €0.407, though declined from €1.90…

Explore "The Amazing Adventure Through the Secrets of the Body," an educational exhibit at Yomiuriland, Tokyo. Enter through the "Pakkun Entrance," a giant mouth, starting a journey of discovering human…